Gabriel Eckermann
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Epilepsy research and treatment
Papers in
-
- Bipolar Disorder and Treatment 5
- Electroconvulsive Therapy Studies 4
- Schizophrenia research and treatment 3
-
- Pharmaceutical studies and practices 7
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Christoph Hiemke (10 shared papers)Pierre Baumann (8 shared papers)S. Ulrich (7 shared papers)B. Müller‐Oerlinghausen (5 shared papers)Peter Riederer (6 shared papers)Gerald Zernig (6 shared papers)Gerd Laux (4 shared papers)I. Gaertner (3 shared papers)
- Journals
- Pharmacopsychiatry (4 papers)Pharmaceuticals (1 paper)Progress in Neuro-Psychopharmacology and Biological Psychiatry (1 paper)Psychosomatics (1 paper)Dialogues in Clinical Neuroscience (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Gabriel Eckermann
21 papers receiving 784 citations
Peers
Comparison fields: 5 of 81
- Biological Psychiatry 77
- Psychiatry and Mental health 338
- Pharmacology 120
- Pharmacology 168
- Toxicology 35
Countries citing papers authored by Gabriel Eckermann
This map shows the geographic impact of Gabriel Eckermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Eckermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Eckermann more than expected).
Fields of papers citing papers by Gabriel Eckermann
This network shows the impact of papers produced by Gabriel Eckermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Eckermann. The network helps show where Gabriel Eckermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Eckermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 316 | |
| 2 | 2005 | 288 | |
| 3 | 2005 | 48 | |
| 4 | 2004 | 34 | |
| 5 | 2021 | 29 | |
| 6 | 2007 | 26 | |
| 7 | 2007 | 13 | |
| 8 | 2018 | 12 | |
| 9 | 2011 | 11 | |
| 10 | 1967 | 7 | |
| 11 | 2017 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2018 | 5 | |
| 14 | 2003 | 5 | |
| 15 | [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group]. | 2006 | 4 |
| 16 | PsiacOnline - Fachdatenbank für Arzneimittelwechselwirkungen in der psychiatrischen Pharmakotherapie. | 2007 | 2 |
| 17 | 2023 | 2 | |
| 18 | 1990 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2006 | 1 |
About Gabriel Eckermann
Gabriel Eckermann is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Pharmacology, Clinical Psychology and Biological Psychiatry, having authored 24 papers that have together received 819 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (7 papers), Bipolar Disorder and Treatment (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Treatment of Major Depression (4 papers), Electroconvulsive Therapy Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Schizophrenia research and treatment (3 papers) and Tryptophan and brain disorders (3 papers). The work is most often cited by research in Biological Psychiatry (77 citations), Psychiatry and Mental health (338 citations), Pharmacology (120 citations), Pharmacology (168 citations) and Toxicology (35 citations). Gabriel Eckermann has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Christoph Hiemke, Pierre Baumann, S. Ulrich, B. Müller‐Oerlinghausen, Peter Riederer, Gerald Zernig, Gerd Laux, I. Gaertner, G. Laux and M. Gerlach. Their work appears in journals such as Pharmacopsychiatry, Pharmaceuticals, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Psychosomatics and Dialogues in Clinical Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.